Skip to main content

Press Releases Tagged with Health Care

FTC Chairman, Members of Congress Call for Legislation to End Sweetheart Pay-for-Delay Deals That Keep Generic Drugs Off the Market (January 13, 2010 )
Bureau of Competition Director Issues Statement on FTCs Closure of its Investigation of Consummated Hospital Merger in Temple, Texas (December 23, 2009 )
FTC Order Ensures Future Competition for Parkinsons and Chemotherapy Drugs That Watsons Acquisition of Arrow Would Have Eliminated (December 2, 2009 )
Commission Issues 2009 Report on U.S. Ethanol Market Concentration; FTC Approves Final Consent Order in Matter Concerning Carilion Clinic (December 1, 2009 )
FTC Order Restores Competition Lost Through Schering-Plough's Acquisition of Merck (October 29, 2009 )
Statement of FTC Chairman Jon Leibowitz On Passage of H.R. 3126, the Consumer Financial Protection Act of 2009 by the House Energy and Commerce Committee (October 29, 2009 )
U.S. Court of Appeals Enforces Subpoenas in FTCs Androgel Investigation; In Separate Case, FTC Files Petition to Compel Enforcement of Subpoena Issued to Boehringer Ingelheim (October 27, 2009 )
Statement of FTC Chairman Jon Leibowitz Regarding the Senate Judiciary Committee's Passage of the Preserve Access to Affordable Generics Act (S. 369) (October 15, 2009 )
FTC Order Prevents Anticompetitive Effects from Pfizers Acquisition of Wyeth (October 14, 2009 )
Commission Order Restores Competition Eliminated by Carilion Clinics Acquisition of Two Outpatient Clinics (October 7, 2009 )
Statement by FTC Chairman Jon Leibowitz on Adoption of the Pay for Delay Amendment to the Americas Affordable Health Choices Act of 2009 by the House Energy and Commerce Committee (July 31, 2009 )
Bureau of Competition Statement Regarding the Announcement that Thoratec Corporation Will Not Proceed with Its Proposed Acquisition of HeartWare International (July 31, 2009 )
FTC Challenges Thoratec's Proposed Acquisition of HeartWare International (July 30, 2009 )
FTC Challenges Carilions Acquisition of Outpatient Medical Clinics (July 24, 2009 )
FTC Testifies on Importance of Competition and Antitrust Enforcement to Lower-Cost, Higher-Quality Health Care (July 16, 2009 )
Commission Approves FY 2008 HSR Premerger Notification Report; FTC Approves Final Consent Order in Matter Concerning Alta Bates Medical Group (July 14, 2009 )
FTC Issues Interim Report on "Authorized Generic" Drugs (June 24, 2009 )
FTC Chairman Leibowitz: Eliminating Pay-for-Delay Pharmaceutical Settlements Would Save Consumers $3.5 Billion Annually (June 23, 2009 )
FTC Testifies on "Competition Issues and Follow-on Biologic Drugs" (June 11, 2009 )
FTC Releases Report on Follow-on Biologic Drug Competition (June 10, 2009 )
Chairman, Commissioners Issue Statement on Endocare, Inc.s Announcement That it has Terminated its Merger Agreement with Galil Medical Ltd. (June 9, 2009 )
Statement of the FTC's Bureau of Competition Regarding the Announcement that CSL Will Not Proceed with its Proposed Acquisition of Talecris Biotherapeutics (June 9, 2009 )
FTC Settles Price-Fixing Charges Against San Francisco Bay Area Doctors Group (June 4, 2009 )
FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies (June 3, 2009 )
FTC Authorizes Suit To Stop CSLs Proposed $3.1 Billion Acquisition of Talecris Biotherapeutics (May 27, 2009 )
FTC Staff Advises Louisiana Legislature That Amended Bill Would Further Restrict Competition to Provide Dental Care to States Most Vulnerable Children (May 22, 2009 )
FTC Staff Advises Louisiana Legislature That Bill Would Restrict Competition to Provide Dental Care to the State's Underserved Children; At FTC's Request, District Court Halts Illegal Operations of Federal Loan Modification Law Center (May 4, 2009 )
FTC Staff Advises Maryland Physician-Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposal to Provide Member Physicians Services Through Clinical Integration Program (April 14, 2009 )
FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company (April 3, 2009 )
FTC Testifies in Support of Bill Banning Pay-for-Delay Settlements Between Brand and Generic Drug Companies (March 31, 2009 )